Sinisa Stojkovic1,2*, MD, PhD; Dejan Milasinovic1, MD; Nenad Bozinovic3, MD; Aleksandar Davidovic4, MD; Dragan Debeljacki5, MD; Nemanja Djenic6, MD; Sasa Hinic7, MD; Nikola Jagic8,9, MD, PhD; Olivera Micic10, MD; Vladimir Mitov11, MD, PhD; Aleksandar N. Neskovic2,12, MD, PhD; Milan Nikolic13, MD; Dragan Sagic2,14, MD, PhD; Goran Stankovic1,2, MD, PhD; on behalf of the Working Group on Catheterisation and Percutaneous Coronary Intervention of Serbia
1. Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia; 2. Faculty of Medicine, University of Belgrade, Belgrade, Serbia; 3. Clinic for Cardiovascular Diseases, Clinical Center Nis, Nis, Serbia; 4. Clinic for Internal Medicine, Clinical
Serbia’s interventional community has been facing the multifaceted challenge of an ageing population with cardiovascular diseases as the primary cause of death nationwide, coronary artery disease (CAD) being the most prevalen
